Aurobindo Pharma climbs after USFDA nod for OTC drug
Shares of Aurobindo Pharma surged over 2 percent today after the firm got final approval from USFDA to manufacture and market its generic Naproxen Sodium tablets used for treatment of osteoporosis.
Mar 21, 2016, 10:33 AM IST